本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

34.20
+1.273.86%
盘后34.200.00000.00%19:30 EDT
成交量:57.35万
成交额:1,946.76万
市值:10.45亿
市盈率:-52.28
高:34.70
开:32.85
低:32.14
收:32.93
52周最高:44.28
52周最低:17.72
股本:3,054.95万
流通股本:2,821.96万
量比:1.54
换手率:2.03%
股息:- -
股息率:- -
每股收益(TTM):-0.6542
每股收益(LYR):-0.8334
净资产收益率:-4.20%
总资产收益率:-1.36%
市净率:2.22
市盈率(LYR):-41.03

数据加载中...

2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

重要事件披露

Form 8-K - Current report
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities